528852-07-5

Basic information

• Product Name: 5-BROMO-5,6,7,8-TETRAHYDROQUINOXALINE
• Synonyms: 5-BROMO-5,6,7,8-TETRAHYDROQUINOXALINE
• CAS NO: 528852-07-5
• Molecular Formula: C₈H₉BrN₂
• Molecular Weight: 213.07446
• Mol File: 528852-07-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-BROMO-5,6,7,8-TETRAHYDROQUINOXALINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-5,6,7,8-TETRAHYDROQUINOXALINE(528852-07-5)
• EPA Substance Registry System: 5-BROMO-5,6,7,8-TETRAHYDROQUINOXALINE(528852-07-5)

Safety Data

• Hazardous Substances Data: 528852-07-5(Hazardous Substances Data)

Usage

General Description

5-Bromo-5,6,7,8-tetrahydroquinoxaline is a chemical compound with a molecular formula C8H9BrN2. It is a brominated derivative of tetrahydroquinoxaline, and is a heterocyclic organic compound. This chemical has a variety of potential applications, including its use as a building block in the synthesis of pharmaceutical drugs and agrochemicals. Additionally, it may have applications in the field of medicinal chemistry, where it could be studied for potential therapeutic effects. 5-Bromo-5,6,7,8-tetrahydroquinoxaline has potential as a research tool in the study of various biological processes and has been the subject of scientific investigation in various fields.

Upstream product

• 34413-35-9 5,6,7,8-tetrahydroquinoxaline 

Downstream Products

• 91-19-0 2,3-diethynylquinoxaline 
• 23719-78-0 2,3-dibromo-quinoxaline 
• 36856-91-4 2-bromo-quinoxaline 
• 2423-66-7 quinoxaline 1,4-di-N-oxide 
• 76982-23-5 5-bromobenzopyrazine 
• 148231-12-3 5,8-dibromoquinoxaline 
• 50998-17-9 6-bromoquinoxaline 
• 1131040-38-4 5,6-dibromoquinoxaline 
• 502612-46-6 5,6,7,8-tetrahydroquinoxalin-5-ylamine 

Relevant articles and documents

Bromination of quinoxaline and derivatives: Effective synthesis of some new brominated quinoxalines

The synthesis of brominated quinoxaline derivatives starting from several kinds of quinoxaline by different bromination strategies was studied. First the synthesis of some brominated quinoxalines was accomplished along with the development of an alternative and effective synthesis of some known compounds. A new, clean, and effective synthetic method for selective reduction of quinoxaline to 1,2,3,4-tetrahydroquinoxaline was also developed. The products obtained were characterized by means of NMR spectroscopy, elemental analyses, and mass spectrometry.

ADRENERGIC COMPOUNDS

Disclosed herein is an alpha - adrenergic compound having a structure. Therapeutic methods, compositions, and medicaments for treating pain are also disclosed herein.

Enzymatic resolution of bicyclic 1-heteroarylamines using Candida antarctica lipase B

Candida antarctica lipase B has been used to kinetically resolve a structurally diverse series of bicyclic 1-heteroaryl primary amines by enantioselective acetylation. High yields of either enantiomer could be obtained with excellent enantioselectivity (90-99% ee), while the undesired enantiomer could, in some cases, be recycled by thermal racemization. The absolute stereochemistry of the products was confirmed by an X-ray crystal structure.